{"id":"https://openalex.org/W4407419476","doi":"https://doi.org/10.1093/ijnp/pyae059.558","title":"RESIDUAL SYMPTOMS IN MAJOR DEPRESSIVE DISORDER: CLINICAL UTILITY OF VENLAFAXINE","display_name":"RESIDUAL SYMPTOMS IN MAJOR DEPRESSIVE DISORDER: CLINICAL UTILITY OF VENLAFAXINE","publication_year":2025,"publication_date":"2025-02-01","ids":{"openalex":"https://openalex.org/W4407419476","doi":"https://doi.org/10.1093/ijnp/pyae059.558","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11814804"},"language":"en","primary_location":{"id":"doi:10.1093/ijnp/pyae059.558","doi":"https://doi.org/10.1093/ijnp/pyae059.558","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ijnp/pyae059.558","pdf_url":null,"source":{"id":"https://openalex.org/S199972112","display_name":"The International Journal of Neuropsychopharmacology","issn_l":"1461-1457","issn":["1461-1457","1469-5111"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311647","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/P4310311647"],"host_organization_lineage_names":["University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Neuropsychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1093/ijnp/pyae059.558","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5093582047","display_name":"Pradeep Purushottamahanti","orcid":"https://orcid.org/0009-0000-8001-1305","observed_orcids":["https://orcid.org/0009-0000-8001-1305"]},"institutions":[{"id":"https://openalex.org/I4387153459","display_name":"Viatris","ror":"https://ror.org/01g1gvr46","country_code":"US","type":"company","lineage":["https://openalex.org/I4387153459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"*Pradeep Purushottamahanti","raw_affiliation_strings":["Global Medical Affairs, Viatris Inc. , Bangalore,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Medical Affairs, Viatris Inc. , Bangalore,","institution_ids":["https://openalex.org/I4387153459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068850044","display_name":"Roger S. McIntyre","orcid":"https://orcid.org/0000-0003-4733-2523","observed_orcids":["https://orcid.org/0000-0003-4733-2523"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Roger Mcintyre","raw_affiliation_strings":["Department of Psychiatry, University of Toronto , Toronto,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of Toronto , Toronto,","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056037962","display_name":"Ofer Agid","orcid":"https://orcid.org/0000-0001-6881-8296","observed_orcids":["https://orcid.org/0000-0001-6881-8296"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Ofer Agid","raw_affiliation_strings":["Department of Psychiatry, University of Toronto , Toronto,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of Toronto , Toronto,","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018168237","display_name":"Egbert Biesheuvel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Egbert Biesheuvel","raw_affiliation_strings":["Biometrics Data Management and Programming , Amstelveen, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biometrics Data Management and Programming , Amstelveen, Netherlands","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2042,"currency":"GBP","value_usd":2693},"apc_paid":{"value":2042,"currency":"GBP","value_usd":2693},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"28","issue":"Supplement_1","first_page":"i313","last_page":"i314"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13118","display_name":"Psychological Treatments and Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9380000233650208},{"id":"https://openalex.org/keywords/venlafaxine-extended-release","display_name":"venlafaxine extended release","score":0.9810000061988831},{"id":"https://openalex.org/keywords/residual-symptoms","display_name":"residual symptoms","score":0.8119999766349792},{"id":"https://openalex.org/keywords/anhedonia","display_name":"anhedonia","score":0.9660000205039978},{"id":"https://openalex.org/keywords/amotivation","display_name":"amotivation","score":0.996999979019165},{"id":"https://openalex.org/keywords/low-energy","display_name":"low energy","score":0.9760000109672546},{"id":"https://openalex.org/keywords/functional-recovery","display_name":"functional recovery","score":0.7229999899864197},{"id":"https://openalex.org/keywords/clinical-remission","display_name":"clinical remission","score":0.7020000219345093},{"id":"https://openalex.org/keywords/montgomery-asberg-depression-rating-scale","display_name":"Montgomery-Asberg Depression Rating Scale","score":0.5130000114440918},{"id":"https://openalex.org/keywords/hamilton-depression-rating-scale","display_name":"Hamilton Depression Rating Scale","score":0.9390000104904175},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.6710000038146973},{"id":"https://openalex.org/keywords/placebo-controlled-comparison","display_name":"placebo comparison","score":0.5960000157356262},{"id":"https://openalex.org/keywords/pooled-analysis-of-clinical-trials","display_name":"pooled analysis of clinical trials","score":0.7149999737739563},{"id":"https://openalex.org/keywords/treatment-response-over-time","display_name":"treatment response over time","score":0.3160000145435333}],"concepts":[{"id":"https://openalex.org/C2776466888","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine","level":4,"score":0.8970493078231812},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.640620231628418},{"id":"https://openalex.org/C155512373","wikidata":"https://www.wikidata.org/wiki/Q287450","display_name":"Residual","level":2,"score":0.6052819490432739},{"id":"https://openalex.org/C2909532165","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine Hydrochloride","level":5,"score":0.46451395750045776},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.45356202125549316},{"id":"https://openalex.org/C3019858935","wikidata":"https://www.wikidata.org/wiki/Q4340209","display_name":"Depressive symptoms","level":3,"score":0.4520268142223358},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.41922762989997864},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3954562842845917},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.38987860083580017},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.368374228477478},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.18701332807540894},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.13210824131965637},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.09421691298484802},{"id":"https://openalex.org/C11413529","wikidata":"https://www.wikidata.org/wiki/Q8366","display_name":"Algorithm","level":1,"score":0.08913731575012207},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.062322646379470825},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.04627251625061035},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/ijnp/pyae059.558","doi":"https://doi.org/10.1093/ijnp/pyae059.558","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ijnp/pyae059.558","pdf_url":null,"source":{"id":"https://openalex.org/S199972112","display_name":"The International Journal of Neuropsychopharmacology","issn_l":"1461-1457","issn":["1461-1457","1469-5111"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311647","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/P4310311647"],"host_organization_lineage_names":["University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Neuropsychopharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11814804","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11814804","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11814804/pdf/pyae059.558.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int J Neuropsychopharmacol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/ijnp/pyae059.558","doi":"https://doi.org/10.1093/ijnp/pyae059.558","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ijnp/pyae059.558","pdf_url":null,"source":{"id":"https://openalex.org/S199972112","display_name":"The International Journal of Neuropsychopharmacology","issn_l":"1461-1457","issn":["1461-1457","1469-5111"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311647","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/P4310311647"],"host_organization_lineage_names":["University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Neuropsychopharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4407419476.pdf","grobid_xml":"https://content.openalex.org/works/W4407419476.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4396533156","https://openalex.org/W7216815222","https://openalex.org/W6958520546","https://openalex.org/W2071410273","https://openalex.org/W2737790027","https://openalex.org/W2113400923","https://openalex.org/W1981792453","https://openalex.org/W2545262119","https://openalex.org/W4385330251","https://openalex.org/W1545716081"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Major":[2],"depressive":[3,448,497],"disorder":[4,449],"(MDD)":[5],"results":[6],"in":[7,21,68,79,116,128,144,158,229,284,346,350,388,422,446,495],"functional":[8,26,43,351,383],"impairment":[9,387],"that":[10,333],"reduces":[11],"quality":[12],"of":[13,18,91,105,111,138,161,173,343,377,442,452],"life.":[14],"The":[15,176,212,225,267,280],"current":[16],"definition":[17],"clinical":[19,109,487],"remission":[20],"MDD":[22],"does":[23],"not":[24,380],"encompass":[25],"recovery":[27],"(Yang":[28],"2022).":[29,55],"Anhedonia,":[30],"amotivation,":[31,339],"low":[32,96,129,335],"energy":[33,130,206],"and":[34,86,99,135,140,142,152,154,187,258,312,322,338,372,419,489],"anxiety":[35,70,454],"are":[36],"the":[37,77,89,136,190,230,285,330,341],"commonest":[38],"residual":[39,81,417],"symptoms":[40,82,348,378,418],"responsible":[41],"for":[42,52,63,125,183,189,200,205,215,234,240,270,291,491],"impairment.":[44,352],"Therefore,":[45],"these":[46],"should":[47],"be":[48],"considered":[49],"key":[50],"targets":[51],"treatment":[53],"(Wang":[54],"Venlafaxine":[56],"extended":[57,444],"release":[58,445],"(XR)":[59],"is":[60,71,83,379],"approved":[61],"worldwide":[62],"treating":[64],"MDD.":[65],"Its":[66],"efficacy":[67,90,127,342],"comorbid":[69],"well":[72],"established":[73],"(Lyndon":[74],"2019),":[75],"but":[76],"evidence":[78],"other":[80],"limited.":[84],"Aims":[85],"Objectives":[87],"Explore":[88],"venlafaxine":[92,112,235,292,344,443,485],"XR":[93,113,236,293,345],"to":[94,262,295,316,382,480],"address":[95],"energy,":[97,336],"anhedonia":[98,146,216,232,337],"amotivation.":[100],"Methods":[101],"A":[102],"pooled":[103],"analysis":[104,177,213,268],"data":[106],"from":[107,167,192,227,282,309,478],"five":[108],"studies":[110],"(1087":[114],"subjects":[115,219,274],"total)":[117],"compared":[118,294],"it":[119],"with":[120,197,424,483],"placebo":[121,241,296],"across":[122,328],"derived":[123,331],"measures":[124,332],"its":[126],"(MADRS":[131,147],"Item":[132],"7":[133],"[lassitude]":[134],"sum":[137],"work":[139],"activities":[141],"retardation":[143],"HAM-D17);":[145],"[anhedonia":[148],"factor]":[149],"items":[150,160],"1,2,6,7":[151],"8)":[153],"amotivation":[155,271,287],"(motivational":[156],"deficits":[157],"3":[159],"HAM-D).":[162],"Primary":[163],"outcomes":[164],"were":[165],"changes":[166,184],"baseline":[168,193,228,283,453],"over":[169,185,260,314],"a":[170,492],"study":[171],"period":[172],"8":[174,196,243,264,298,318],"weeks.":[175],"used":[178],"Mixed":[179],"Model":[180],"Repeated":[181],"Measures":[182],"time":[186,261,315],"ANCOVA":[188],"change":[191,226,281],"at":[194,255],"week":[195,256,263,310,317],"LOCF":[198],"employed":[199],"missing":[201],"data.":[202],"Results":[203],"Efficacy":[204,441],"has":[207],"been":[208],"demonstrated":[209],"(Fagiolini":[210],"2023).":[211],"set":[214,269],"included":[217,272],"839":[218],"(venlafaxine":[220,275],"XR,":[221,276],"456;":[222],"placebo,":[223,278],"383).":[224],"MADRS":[231],"sub-scale":[233],"was":[237,289,325],"greater":[238],"than":[239],"after":[242,297],"weeks":[244,299],"(mean,":[245,300],"95%":[246,301],"CI:":[247,302],"-":[248],"2.73[-3.63,":[249],"-1.82],":[250],"p<0.0001),":[251,305],"reaching":[252,306],"statistical":[253,307],"significance":[254,308],"2":[257,311],"increasing":[259,313,484],"(Figure":[265,319],"1a).":[266],"1087":[273],"585;":[277],"502).":[279],"HAM-D":[286],"measure":[288],"higher":[290],"-0.78[-1.04,":[303],"-0.52],":[304],"1b).":[320],"Discussion":[321],"Conclusion":[323],"There":[324],"significant":[326],"improvement":[327],"all":[329],"evaluated":[334],"demonstrating":[340],"alleviating":[347],"implicated":[349],"References":[353],"1.Yang":[354],"H,":[355,361,367],"Gao":[356,407],"S,":[357,467],"Li":[358],"J,":[359,363,400,410],"Yu":[360],"Xu":[362],"Lin":[364],"C,":[365,369,408,438],"Yang":[366],"Teng":[368],"Ma":[370],"H":[371],"Zhang":[373,397],"N":[374],"(2022)":[375],"Remission":[376],"equal":[381],"recovery:":[384],"Psychosocial":[385],"functioning":[386,421],"major":[389,447,496],"depression.":[390,425],"Psychiatry":[391],"13:915689.":[392],"2.Wang":[393],"Y,":[394],"Wang":[395],"G,":[396],"N,":[398,465],"Huang":[399],"Wu":[401],"W,":[402,412],"Jia":[403],"F,":[404],"Liu":[405],"T,":[406],"Hu":[409],"Hong":[411],"Fang":[413],"Y.":[414],"Association":[415],"between":[416],"social":[420],"patients":[423],"Compr":[426],"Psychiatry.":[427],"2020":[428],"Jan":[429],"22;98:152164.":[430],"3.Lyndon":[431],"GJ,":[432],"Prieto":[433],"R,":[434],"Wajsbrot":[435],"DB,":[436],"Allgulander":[437],"Bandelow":[439],"B.":[440],"patients:":[450],"effect":[451],"symptom":[455],"severity.":[456],"Int":[457],"Clin":[458],"Psychopharmacol.":[459],"2019":[460],"May;34(3):110-118.":[461],"4.Fagiolini":[462],"A,":[463],"Cardoner":[464],"Pirildar":[466],"Ittsakul":[468],"P,":[469],"Ng":[470],"B,":[471],"Duailibi":[472],"K,":[473],"El":[474],"Hindy":[475],"N.":[476],"Moving":[477],"serotonin":[479],"serotonin-norepinephrine":[481],"enhancement":[482],"dose:":[486],"implications":[488],"strategies":[490],"successful":[493],"outcome":[494],"disorder.":[498],"Expert":[499],"Opin":[500],"Pharmacother.":[501],"2023":[502],"Sep-":[503],"Dec;24(15):1715-1723.":[504]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2025-02-13T00:00:00"}